๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma

โœ Scribed by ?astowska, M. ;Van Roy, N. ;Bown, N. ;Speleman, F. ;Roberts, P. ;Lunec, J. ;Strachan, T. ;Pearson, A.D.J. ;Jackson, M.S.

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
85 KB
Volume
36
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Molecular cytogenetic delineation of 17q
Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines
โœ Maria |fLastowska; Nadine Van Roy; Nick Bown; Frank Speleman; John Lunec; Tom St ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 408 KB ๐Ÿ‘ 2 views

It has recently been recognized that unbalanced translocations resulting in the gain of material from 17q are the most common chromosomal changes in neuroblastoma. These rearrangements are associated with established indicators of bad prognosis and poor patient survival. We have used 13 fluorescence

Promiscuous translocations of chromosome
Promiscuous translocations of chromosome arm 17q in human neuroblastomas
โœ Maria Lastowska; Paul Roberts; Andrew D. J. Pearson; Ian Lewis; John Wolstenholm ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 187 KB ๐Ÿ‘ 1 views

Deletions of chromosome arm 1p and amplification of the MYCN oncogene are well-recognized genetic changes in neuroblastoma cells. Technical difficulties in cytogenetic analysis of this tumour have hampered the recognition of other recurring abnormalities, but recent use of molecular cytogenetic tech

Molecular cytogenetics localizes two new
Molecular cytogenetics localizes two new breakpoints on 11q23.3 and 21q11.2 in myelodysplastic syndrome with t(11;21) translocation
โœ Iwona Wlodarska; Licia Selleri; Roberta La Starza; Caroline Paternotte; Glen A. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 371 KB

Translocation t(11;21)(q24;q11.2) is a rare but recurrent chromosomal abnormality associated with myelodysplastic syndrome (MDS) that until now has not been characterized at the molecular level. We report here results of a molecular cytogenetic analysis of this translocation in a patient with refrac